title: Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus.
authors: Department of Dermatology, Toranomon Hospital, Tokyo, Japan. Electronic address: akok@toranomon.gr.jp.
authors: Akiko
authors: A
authors: Kishi
authors: Department of Dermatology, Toranomon Hospital, Tokyo, Japan.
authors: Nobukazu
authors: N
authors: Hayashi
authors: Department of Dermatology, Toranomon Hospital, Tokyo, Japan.
authors: Kuniaki
authors: K
authors: Ohara
authors: Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
authors: Keiji
authors: K
authors: Aoki
authors: Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
authors: Ichimaro
authors: I
authors: Yamada
authors: Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
authors: Kenji
authors: K
authors: Ikeda
authors: Department of Hepatology, Toranomon Hospital, Tokyo, Japan.
authors: Hiromitsu
authors: H
authors: Kumada
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D044466:Asian People / Q000706:statistics & numerical data; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000187:drug effects / Q000302:isolation & purification*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D009842:Oligopeptides; C486464:telaprevir